Dr. Lal PathLabs Limited (NSE:LALPATHLAB)
India · Delayed Price · Currency is INR 1,363.80
+3.80 (0.28%)
Mar 9, 2026, 3:30 PM IST
Dr. Lal PathLabs Market Cap
Dr. Lal PathLabs has a market cap or net worth of 227.26 billion as of March 9, 2026. Its market cap has increased by 3.96% in one year.
Market Cap
227.26B
Enterprise Value
216.15B
Revenue
26.63B
Ranking
n/a
PE Ratio
43.00
Stock Price
1,363.80
Market Cap Chart
Since December 23, 2015, Dr. Lal PathLabs's market cap has increased from 68.18B to 227.26B, an increase of 233.32%. That is a compound annual growth rate of 12.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 227.26B | -8.27% |
| Dec 31, 2025 | 247.75B | -0.90% |
| Dec 31, 2024 | 250.00B | 16.78% |
| Dec 29, 2023 | 214.08B | 14.42% |
| Dec 30, 2022 | 187.09B | -40.76% |
| Dec 31, 2021 | 315.81B | 66.10% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.28T |
| Divi's Laboratories | 1.69T |
| Apollo Hospitals Enterprise | 1.11T |
| Cipla | 1.07T |
| Emcure Pharmaceuticals | 268.42B |
| Inventurus Knowledge Solutions | 228.10B |
| Pfizer | 221.85B |
| Sai Life Sciences | 219.60B |